It was reported that there were concerns this cardiac resynchronization therapy defibrillator (crt-d) accelerated the existing ventricular tachycardia (vt).Technical services (ts) reviewed the device data and noted that the crt-d provided appropriate anti-tachycardia pacing (atp) therapy, but that the vt rate accelerated after the therapy was delivered.This device subsequently delivered a shock which broke the arrhythmia.Further consultation with an electrophysiology (ep) specialist was recommended.This device remains in service.No additional adverse patient effects were reported.
|